Journal article
Ovarian cancer risk and survival according to tumor sex hormone receptor expression: An ovarian Cancer association consortium and ovarian tumor tissue analysis consortium pooled analysis
Z Fu, L Borho, SE Taylor, LE Kelemen, A DeFazio, PM Webb, M Köbel, NS Meagher, R Na, AC Antoniou, AH Brand, CJ Kennedy, N Nevins, PDP Pharoah, YB Shvetsov, SJ Winham, J Alsop, MW Beckmann, A Bolithon, J Boros Show all
Gynecologic Oncology | Published : 2025
Abstract
Objective: Many epithelial ovarian cancer (EOC) risk factors relate to sex hormones. The association between these factors and the expression of androgen receptor (AR), estrogen receptor-α (ER), and progesterone receptor (PR) in tumors is unknown. Method: We linked epidemiologic, AR/ER/PR tumor expression, and survival data from 19 studies in the Ovarian Cancer Association Consortium (OCAC; 4762 cases, 20,888 controls) and the Ovarian Tumor Tissue Analysis (OTTA) consortium (5737 cases). We estimated odds ratios (ORs) and 95 % confidence intervals (CIs) between hormonally-linked factors and tumor AR/ER/PR expression using polytomous logistic regression. We assessed survival by AR/ER/PR tumor..
View full abstractRelated Projects (3)
Grants
Awarded by Ministerio de Ciencia, Innovación y Universidades